|
|
|
|
|
| March 8, 2012 | ISSUE NUMBER 241 VOL 8 |
|
Biotech
Will VC Funding in Colorado Stifle Innovation?
Small biotechs have always been synonymous with innovation. And the increase in money invested in Colorado companies parallels a national trend. While this model may generate financial returns, what effect will the flood of new money have on the biotech ecosystem? ...Read More
Strategy
Missed Opportunities in Advanced Data Analytics
In an exclusive PharmExec.com Q&A, Brad Sitler, principle industry consultant at SAS's Center for Health Analytics and Insights group and EAB member, sits down to discuss the opportunities that advanced data analytics can bring to the bottom line, and why pharma has been slow to embrace a more quantified approach. ...Read More
Marketing
Creating the Right Digital Mix
To keep pace with technology change and deploy the newest tools to attract customers, there has to be a strategy based on careful analysis of the actual performance of the most recent service innovations. This is true not just for social media plays, but also multichannel executions targeting HCPs, or a physician finder on unbranded disease awareness sites for consumers. ...Read More
Regulation
Healthcare and the Supreme Court
This month marks the opening of key deliberations on three crucial parts of healthcare reform. Guest Blogger Tom Norton explains what's at stake.
...Read More
|
|
|
 // Molecular diagnostics firm CombiMatrix (Irvine, CA) has appointed Richard Ding, CEO of bioTheranostics, and Joseph Limber, President and CEO of Prometheus Laboratories, to its Board of Directors.
// Dr. Eeva-Kaarina Koskelo was named Executive Director, Clinical Development Services, Pediatrics, at Premier Research Group (Philadelphia). // CytomX Therapeutics (San Francisco) announced the appointment of Hoyoung Huh, MD, PhD, as Chairman of its Board of Directors. Former chairman Charles Homcy, MD, will remain on the Board as well.
|
|
|
|
|
|
|
 |
 |
|
|
|
|
 |
 |
|
 |
What do you see as the chief obstacle to achieving growth in the emerging markers?
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
